Short Interest in Upexi, Inc. (NASDAQ:UPXI) Rises By 33.0%

Upexi, Inc. (NASDAQ:UPXI) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 116,800 shares, a growth of 33.0% from the March 31st total of 87,800 shares. Currently, 0.8% of the company’s stock are short sold. Based on an average trading volume of 105,000 shares, the days-to-cover ratio is presently 1.1 days.

Upexi Price Performance

NASDAQ UPXI opened at $0.50 on Monday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.33 and a current ratio of 0.93. Upexi has a one year low of $0.43 and a one year high of $4.55. The firm’s fifty day moving average is $0.56 and its two-hundred day moving average is $0.92.

Upexi (NASDAQ:UPXI) last posted its quarterly earnings data on Wednesday, February 14th. The company reported ($0.12) EPS for the quarter. The business had revenue of $21.83 million during the quarter. Upexi had a negative net margin of 22.63% and a negative return on equity of 40.72%.

Insider Buying and Selling

In related news, CEO Allan Marshall purchased 103,013 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were purchased at an average cost of $0.70 per share, for a total transaction of $72,109.10. Following the purchase, the chief executive officer now directly owns 2,861,881 shares of the company’s stock, valued at $2,003,316.70. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 41.58% of the stock is owned by company insiders.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Upexi stock. Team Hewins LLC acquired a new stake in Upexi, Inc. (NASDAQ:UPXI) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 428,254 shares of the company’s stock, valued at approximately $497,000. Team Hewins LLC owned 2.11% of Upexi as of its most recent filing with the Securities and Exchange Commission (SEC). 5.68% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Alliance Global Partners reiterated a “neutral” rating and set a $1.25 price target (down from $3.00) on shares of Upexi in a research note on Thursday, February 15th.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.